BioDelivery Sciences International Inc
F:BD5
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
BioDelivery Sciences International Inc
F:BD5
|
US |
|
Vita Coco Company Inc
NASDAQ:COCO
|
US |
|
EMvision Medical Devices Ltd
ASX:EMV
|
AU |
|
Oncolytics Biotech Inc
TSX:ONC
|
CA |
|
A
|
AustAsia Group Ltd
HKEX:2425
|
CN |
|
Global Self Storage Inc
NASDAQ:SELF
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BD5's stock price target?
Not Available
BD5 doesn't have any price targets made by Wall Street professionals.
What is BioDelivery Sciences International Inc's Revenue forecast?
Projected CAGR
30%
For the last 8 years the compound annual growth rate for BioDelivery Sciences International Inc's revenue is 40%. The projected CAGR for the next 1 year is 30%.
What is BioDelivery Sciences International Inc's Net Income forecast?
Projected CAGR
-48%
The compound annual growth rate of BioDelivery Sciences International Inc's net income for the next 1 year is -48%.